脑部放疗，上午比下午敏感许多！
5 Y" r6 r' s% B0 F1 f% `
. e: z( W3 U3 X8 o8 D0 e6 a6 q: G( V5 K
% ~4 G) @* \% f' B0 h& C3 D1 `Cancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.
' a J8 a; ?+ f( QGamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?" s n8 O: M- `2 Y* S3 }+ R, S: F
Rahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.
5 [; Z x# B. \7 [. C' C' ~) r( w9 e# xSourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.
$ j7 P- ^1 u2 e5 m. S! @
; J/ Q8 u- B }Abstract- D- H+ o. {: t+ X7 H; ^/ C( g
BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.
) Q, c: q* X: d% r( W' Z Z+ T$ D+ {1 a
METHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.5 G% g% j8 \3 b6 b
# r) L+ i5 f3 K6 H! I: D ?/ cRESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).
z3 A& h7 \9 R) |/ I
* S& } d0 a0 O3 I sCONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.
, j+ u: r$ T" W3 k, S3 J
, c$ E7 e4 @2 L, i/ k |
11011102001537 )
显身卡
